BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33381388)

  • 1. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.
    Zhang W; Zhou Y; Li C; Xu S; Li M; Liu W; Ma Y; Wang H
    Anal Cell Pathol (Amst); 2020; 2020():2872479. PubMed ID: 33381388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 3. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
    BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma.
    Liu L; Lu Z; Hu X; Su T; Su L; Pu H
    Medicine (Baltimore); 2021 Jul; 100(28):e26597. PubMed ID: 34260541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
    Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q
    Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of AQP3 and AQP5 in esophageal squamous cell carcinoma correlates with aggressive tumor progression and poor prognosis.
    Liu S; Zhang S; Jiang H; Yang Y; Jiang Y
    Med Oncol; 2013; 30(3):636. PubMed ID: 23797770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma.
    Han N; Zhang YY; Zhang ZM; Zhang F; Zeng TY; Zhang YB; Zhao WC
    Medicine (Baltimore); 2021 May; 100(20):e25932. PubMed ID: 34011067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.
    Pan F; Yao J; Chen Y; Zhou C; Geng P; Mao H; Fang X
    Int J Clin Exp Pathol; 2014; 7(6):2838-49. PubMed ID: 25031703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
    Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
    Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Wang WW; Zhu WG; Yu CH; Tao GZ; Wu QQ; Song YQ; Pan P; Tong YS
    Mol Carcinog; 2016 Dec; 55(12):2095-2105. PubMed ID: 26756568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population.
    Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J
    Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
    Lin X; Xu XY; Chen QS; Huang C
    Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation.
    Ueno N; Shimizu A; Kanai M; Iwaya Y; Ueda S; Nakayama J; Seo MK
    J Histochem Cytochem; 2016 Jan; 64(1):7-17. PubMed ID: 26487184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC7A9 as a Potential Biomarker for Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma.
    Baba H; Kanda M; Sawaki K; Nakamura S; Ueda S; Shimizu D; Koike M; Kodera Y; Fujii T
    Ann Surg Oncol; 2022 Apr; 29(4):2699-2709. PubMed ID: 34773193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.